{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:26:45Z","timestamp":1790803605822,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024J011081"],"award-info":[{"award-number":["2024J011081"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.lungcan.2026.108918","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:25:15Z","timestamp":1768202715000},"page":"108918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Combined intrathecal therapy via Ommaya reservoir and whole-brain radiotherapy improves survival in EGFR-mutant NSCLC patients with leptomeningeal metastases: a real-world cohort study"],"prefix":"10.1016","volume":"213","author":[{"given":"Meifang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.108918_b0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2019.05.019","article-title":"Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors","volume":"116","author":"Hendriks","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2026.108918_b0010","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(17)30689-7","article-title":"Leptomeningeal metastases in non-small-cell lung cancer","volume":"19","author":"Cheng","year":"2018","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108918_b0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood-brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.lungcan.2026.108918_b0020","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal metastases in patients with NSCLC with EGFR mutations","volume":"11","author":"Li","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108918_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/JTO.0b013e3182773f21","article-title":"Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors","volume":"8","author":"Lee","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.108918_b0030","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jtho.2021.04.018","volume":"16","author":"Fan","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.108918_b0035","series-title":"Ommaya Reservoir","author":"Hall","year":"2025"},{"issue":"18","key":"10.1016\/j.lungcan.2026.108918_b0040","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","article-title":"Leptomeningeal metastases in the MRI era","volume":"74","author":"Clarke","year":"2010","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.lungcan.2026.108918_b0045","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","article-title":"Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology","volume":"29","author":"Glass","year":"1979","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.lungcan.2026.108918_b0050","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s004150050459","article-title":"The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis","volume":"246","author":"Straathof","year":"1999","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.108918_b0055","first-page":"193","article-title":"Diagnosis and treatment consensus of brain and leptomeningeal metastasis from lung cancer","volume":"18","author":"Wu","year":"2018","journal-title":"J. Evid. Based Med."},{"issue":"6","key":"10.1016\/j.lungcan.2026.108918_b0060","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1200\/JCO.19.00457","article-title":"Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: the BLOOM study","volume":"38","author":"Yang","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.108918_b0065","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jtho.2019.05.007","article-title":"Activity of EGFR tyrosine kinase inhibitors in NSCLC with refractory leptomeningeal metastases","volume":"14","author":"Flippot","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.108918_b0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13014-020-01627-y","article-title":"Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study","volume":"15","author":"Zhen","year":"2020","journal-title":"Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108918_b0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11060-023-04483-4","article-title":"Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis","volume":"165","author":"Hong","year":"2023","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.lungcan.2026.108918_b0080","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fonc.2018.00509","article-title":"The comparative treatment of intraventricular chemotherapy by Ommaya reservoir vs. lumbar puncture in patients with leptomeningeal carcinomatosis","volume":"8","author":"Montes de Oca Delgado","year":"2018","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2026.108918_b0085","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/JTO.0000000000000669","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors for non-small-cell lung cancer patients with leptomeningeal carcinomatosis","volume":"10","author":"Liao","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108918_b0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JTO.0b013e3182398e4f","article-title":"Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy","volume":"7","author":"Morris","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.108918_b0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11060-021-03924-2","article-title":"Leptomeningeal metastases: the future is now","volume":"156","author":"Lukas","year":"2022","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.lungcan.2026.108918_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2022.09.013","article-title":"Leptomeningeal metastases in non-small cell lung cancer: DIAGNOSIS and treatment","volume":"174","author":"Wang","year":"2022","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2026.108918_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","article-title":"Leptomeningeal metastasis from non-small cell lung cancer and current landscape of treatments","volume":"29","author":"Ozcan","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"24","key":"10.1016\/j.lungcan.2026.108918_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40703","article-title":"Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.lungcan.2026.108918_b0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/1759-7714.13738","article-title":"Osimertinib combined with bevacizumab for leptomeningeal metastasis from EGFR-mutation non-small cell lung cancer: a phase II single-arm prospective clinical trial","volume":"12","author":"Lu","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"23","key":"10.1016\/j.lungcan.2026.108918_b0120","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1200\/JCO.24.01061","article-title":"Leptomeningeal metastasis in the era of CNS-penetrant tyrosine kinase inhibitor therapy","volume":"42","author":"Jeng","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.108918_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101832","article-title":"Therapeutic role of EGFR - Tyrosine kinase inhibitors in non-small cell lung cancer with leptomeningeal metastasis","volume":"39","author":"Jia","year":"2024","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.108918_b0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jtho.2024.09.1385","article-title":"High-dose furmonertinib in patients with EGFR-mutated NSCLC and leptomeningeal metastases: a prospective real-world study","volume":"20","author":"Chen","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.108918_b0135","article-title":"The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study","author":"Zheng","year":"2025","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.108918_b0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02334413","article-title":"Hypoglycorrhachia in leptomeningeal carcinomatosis. A pathophysiological study","volume":"9","author":"Jann","year":"1988","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.lungcan.2026.108918_b0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jocn.2018.02.014","article-title":"Lactate dehydrogenase as a prognostic marker in neoplastic meningitis","volume":"51","author":"Cacho-Diaz","year":"2018","journal-title":"J. Clin. Neurosci."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:04:58Z","timestamp":1774029898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"alternative-id":["S0169500226000139"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.108918","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined intrathecal therapy via Ommaya reservoir and whole-brain radiotherapy improves survival in EGFR-mutant NSCLC patients with leptomeningeal metastases: a real-world cohort study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.108918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108918"}}